Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  05/13/2010
 
Trade Name:  Taxotere
 
Generic or Proper Name (*):  docetaxel
 
Indications Studied:  Solid Tumors
 
Therapeutic Category:  Antineoplastic
 
Ages Studied:  1 - 22 years
 
Study #:  1
 
Study Type:  Pharmacokinetic/Tolerability
 
Study Design:  Open label/Population Pharmacokinetic
 
No Patients:  61
 
No Centers:  16
 
No Countries:  1
 
BPCA(B), PREA(P):  B
 
-
-